High Dose Radiolabeled Antibody Therapy of Lymphoma 1

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Autologous bone-marrow transplantation.

  1987cited by this paper
• Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas.

  1987cited by this paper
• A unique antigen on mature B cells defined by a monoclonal antibody.

  1986cited by this paper
• Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies.

  1985cited by this paper
• Experimental radiotherapy of murine lymphoma with 131I-labeled anti-Thy 1.1 monoclonal antibody.

  1985cited by this paper
• Therapy of murine leukemia with monoclonal antibody against a normal differentiation antigen

  1983cited by this paper
• Monoclonal antibody therapeutic trials in seven patients with T-cell lymphoma.

  1983cited by this paper
• IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells.

  1982cited by this paper
• Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma.

  1982cited by this paper
• Anti-transferrin receptor monoclonal antibody and toxin–antibody conjugates affect growth of human tumour cells

  1981cited by this paper
• Mouse leukemia: therapy with monoclonal antibodies against a thymus differentiation antigen.

  1980cited by this paper
• Mechanism of B cell lymphoma immunotherapy with passive xenogeneic anti-idiotype serum.

  1980cited by this paper
• Antibody-mediated suppression of grafted lymphoma. IV. Influence of time of tumor residency in vivo and tumor size upon the effectiveness of suppression by syngeneic antibody

  1976cited by this paper

• No citing papers are available for this paper.